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The  extensive amino acid sequence diversity of Ig variable  (V) j  regions is 
known  to  be  derived  from  both  evolutionary  and  somatic  processes  (I-3). 
Comparison of amino acid sequences of mouse myeloma and hybridoma K light 
(L)  chains,  for example,  indicates  that  these  sequences can  be arranged  into 
groups such that members of a  group are more similar to each other than  to 
members of other groups (4-6).  In  the case of mouse ~ L  chains, multiple V 
region genes have been observed (7,  8) for most groups of V  regions tested. 
Thus, the multiple germ line V~ genes provide a portion of the V region diversity 
observed at the protein level. Additional diversity is introduced by permitting 
each V~ gene to join with any one of four different active joining (J) segments, 
by  introducing junctional  diversity during  the joining  event,  and  by  somatic 
mutation (for review, see refs. 3 and 9). 
Several mouse V~ genetic markers have been described which involve charac- 
teristic V~ regions that are expressed by some inbred strains of mice, but not by 
others. These genetic markers have been detected by peptide mapping (10,  11) 
and isoelectric focusing (12,  13) of L chains from normal mouse serum Ig, by 
analysis of expression of various idiotypes (14,  15), and by isoelectric focusing of 
L chains of antiphosphorylcholine antibodies that bear the H8 idiotype (16). All 
of these genetic polymorphisms are determined by genes closely linked to the 
Lyt-2 and Lyt-3 loci on chromosome 6 (17,  18), the same chromosome that bears 
the K L  chain structural  genes (19).  A  system for nomenclature of genes that 
determine these V~ polymorphisms has been proposed (20). 
One of these V~ polymorphisms, called the I,-peptide marker, was detected by 
tryptic peptide mapping of reduced and [14C]iodoacetic acid-alkylated L chains 
from normal serum Ig of unimmunized mice (10,  11).  This analysis detected a 
heterogeneous group of VK regions that accounts for <5% of the total L chains 
expressed by IB-positive  strains.  To obtain  myelomas producing homogeneous 
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examples  of IB-positive L  chains,  it  was  necessary to cross  the  genetic  marker 
onto  the  BALB/c  genetic  background,  since  none  of the  mye/oma-inducible 
strains expresses the marker (21). Of ~200 myelomas induced in the C.C58 and 
C.AKR strains, several were found to correspond to both the IB-peptide marker 
and  the  EF1"  marker  described  by  Gibson  et  al.  (12).  Amino  acid  sequence 
analysis  demonstrated  that  these  L  chains  belonged  to  a  group  of V,  regions 
apparently not expressed by either BALB/c or NZB, and which we referred to 
as the  V~Ser group,  because all such proteins observed had an  unusual  amino- 
termninal serine  residue (21).  A  major question  that  remains  to be answered  is 
whether strains  that  do not  express V~Ser-like L  chains lack  V~Ser genes alto- 
gether,  or  whether  they  contain  the  genes,  but  fail  to  express  them  due  to 
regulatory controls. 
To  further  characterize  the  VKSer  group,  full-length  complementary  DNA 
(cDNA)  clones  have  been  produced  from  rnRNA  coding for the  IB-positive L 
chain of the C.C58  M75 myeloma. The entire sequence of one cDNA clone has 
been determined and compared with the known collection of BALB/c and NZB 
chain  sequences.  Results  suggest that  the nucleotide sequence of the  M75  V 
region is different from all known V~ regions throughout most of its length. Use 
of a  the 5'  region of this clone as a  probe for V~Ser-specific sequences in  Barn 
HI,  Hind  III,  and  Eco RI  digests  of liver DNA  of a  large  number of inbred, 
recombinant, and recombinant inbred strains has revealed at least one strongly 
hybridizing  sequence  in  each  strain  tested.  Thus,  strains  that  do  not  express 
V~Ser-associated phenotypic markers do not lack V,Ser-related DNA sequences. 
However,  strains  could  be  divided  into  two  groups  based  on  the  sizes  of the 
strongly-hybridizing  fragments.  Complete  correlation  was  observed  between 
expression of V~Ser-associated phenotypic markers and the presence of strongly 
hybridizing Barn  HI, Hind III, and Eco RI  fragments of 3.2  kilobases (kb),  2.8 
kb, and 2.1  kb, respectively. 
Materials and  Methods 
Mice, Myelomas,  and DNA.  The C.C58 and C.AKR inbred strains of mice, which bear 
the Lyt-2" and Lyt-3  ~  alleles and VK genetic polymorphisms of the C58/J and AKR/J strains, 
respectively, on the BALB/cAn genetic background (22), and the B6/Lyt-2  a, Lyt-3" strain, 
which contains the corresponding genes of the RF strain on the C57BL/6 background 
(23),  were bred in our laboratory. The C.C58 and C.AKR strains were inbred after 19 
backcross generations. Mice of the congenic partner strain, BALB/cAn, were the gift of 
Dr.  H.  N.  Eisen,  Massachusetts  Institute  of  Technology,  Cambridge.  Mice  of the 
B6.PL(85NS) strain (24) and DNA from mice of the NAK strain (25) were the gifts of 
Dr. D. Gibson, University of Sherbrooke, Quebec, Canada. All other mice were purchased 
from the Jackson Laboratory, Bar Harbor, ME. 
The C.C58 M75 myeloma was induced in an earlier inbreeding (N9) by three bimonthly 
intraperitoneal injections of pristane  (tetramethylpentadecane), as described by Potter 
(26). The tumor had been adapted to subcutaneous growth, and small nonnecrotic tumors, 
~1.5 cm  in  diameter,  were quick-frozen in  liquid nitrogen for mRNA  isolation. DNA 
from the C.C58 M75 myeloma and from livers of various strains was isolated from tissue 
frozen in the same manner. DNA from A/J mice and from AKXL recombinant inbred 
strains (27) was purchased from The Jackson Laboratory, Bar Harbor, ME. 
Bacterial Strains and Vectors.  The primer and linker vectors (28) in E. coli K 12 HB 101 
were the kind gifts of Dr. H. Okayama and Dr. P.  Berg, Stanford University School of 
Medicine. The plasmid pUCI8 (29) and E.  coli K12 GM33 (30) were obtained from Dr. GOLDRICK ET  AL.  715 
R. Meyer,  University of Texas, Austin.  The M13mp8 and M13mp9 phage, and E.  coli 
K12 JM 103 strain (31) were obtained from Dr. J. Walker, University of Texas, Austin. 
The RR1  strain ofE. coli K12 and the pBR322 clone, which contained the 3.1  kb Hind 
III/Bam HI BALB/c genomic C~ (constant) fragment (32,  33) were the gifts of Dr.  P. 
Tucker, University of Texas Health Sciences Center, Dallas. 
Enzymes.  Restriction enzymes were purchased from Bethesda Research Laboratories, 
Inc.  (Gaithersberg,  MD),  Boehringer-Mannheim  Biochemicals  (Indianapolis,  IN),  and 
New England Biolabs (Beverley, MA). Avian myoblastosis virus reverse transcriptase was 
purchased from Life Sciences, Inc., St. Petersburg, FL. E. coli DNA polymerase I (Klenow 
fragment), T4 DNA polymerase, and a kit for radiolabeling DNA by strand-replacement 
synthesis with T4 DNA polymerase were purchased from Bethesda Research Laboratories, 
Inc. E. coli DNA ligase was purchased from P-L Biochemicals, Piscataway, NJ. A kit (409 
Sequencing Pack) for nucleotide sequence analysis using the dideoxynucleotide procedure 
was obtained from New England Biolabs, Beverley, MA. 
Isolation  ofmRNA.  PolyA  ÷ RNA was isolated from the C.C58 M75 myeloma by the 
guanidine  thiocyanate  method  of Chirgwin  et al.  (34),  followed by two passages over 
oligo(dT)-cellulose (Sigma Chemical Co., St. Louis, MO). Electrophoresis in formaldehyde 
gels, and  Northern blot analyses were performed as described by Rave et al.  (35),  and 
hybridization in 50% (vol/vol) formamide was as described by Thomas (36). 
Probe for  Screening  cDNA  Library.  A  pBR322  subclone  was  obtained  from  Dr.  P. 
Tucker. It contained a 3.1 kb Hind III//Bam HI fragment containing the BALB/c mouse 
C, region, and a portion of 5' and 3' flanking regions (32, 33).  The 3.1  kb fragment was 
excised and isolated by two cycles of agarose gel electrophoresis, and radiolabeled with ,~- 
[32p]dATP (New England Nuclear, Boston, MA,  3,200 Ci/mmol) by nick-translation, as 
described by Maniatis et al. (37).  Specific radioactivity of the resulting DNA was ~5  X 
106 cpm/~g. 
Procedure for cDNA Cloning.  Complementary DNA cloning of polyA  + RNA from the 
C.C58 M75 myeloma was performed essentially as described by Okayama and Berg (28). 
After second-strand synthesis and ligation, the resulting DNA was used to transform both 
E. coli K12 strain HB101 (Rec A-) and RRI (Rec A +) as described and plated on L-broth 
agar that contained 250 #g/ml Carbenicillin (Geopen) (Pfizer, Inc., New York). Colonies 
were picked onto nitrocellulose filters (Millipore Corp., Bedford, MA) and subjected to 
colony hybridization as described by Davis et al. (38), using the nick-translated Hind III/ 
Bam HI genomic C, fragment as probe. Colonies that gave positive hybridization signals 
were grown in L broth containing 250 tzg/ml carbenicillin, and plasmid DNA was isolated 
by a cleared lysate procedure, essentially as described by Katz et al. (39). 
Restriction Mapping.  For restriction mapping of cloned DNA, restriction enzymes were 
generally used under the conditions specified by their suppliers. Fragments were analyzed 
by electrophoresis on agarose gels (0.8-1.5%) in the presence of ethidium bromide. 
Southern  Hybridization  of Genomic DNA.  Genomic DNA was isolated from myeloma 
and liver tissue as described by Blatmer et al. (40) and Maniatis et al. (37).  DNA samples 
(10  #g each) were digested  with  the  appropriate restriction  nuclease and subjected  to 
electrophoresis on 0.6% agarose gels. The DNA was transferred to nitrocellulose filters 
(BA85; Schleicher and Schuell, Keene, NH), prehybridized, then hybridized with radio- 
active probe (see below) in 50% formamide at 41°C, essentially as described by Davis et 
al. (38). Filters were washed three times (10 min each) at 55 ° in 2 × SSC (standard sodium 
citrate), 0.1% SDS followed by two washes (15 min each) at 55 ° in 0.1  ×  SSC, 0.1% SDS. 
Autoradiography  was  performed  at  -70°C  with  Dupont  Lightning  Plus  intensifying 
screens. 
The source of probe for Southern hybridization was a 200 base pairs (bp) Pst I/Kpn I 
DNA fragment that contained the  5'  end  of the putative full-length  K L  chain  cDNA 
clone  of interest,  p9(35)  (see  below).  This  fragment  was  subcloned  into  the  plasmid, 
pUC18(29), and the resulting plasmid was cleaved at one end of the insert with Pst I and 
radiolabeled with c~-[S2p]dATP (sp act 3,000  Ci/mmol) by strand-replacement synthesis 
with  T4  DNA polymerase as described  by O'Farrell (41).  Specific radioactivity of the 
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DNA Sequence Analysis.  DNA  sequencing  was performed by the  dideoxynucleotide 
chain termination method of Sanger and coworkers (42) using cloning vectors M 13rap8 
and M 13mp9 and the sequencing strategy designed by Messing and coworkers (31,  43, 
44). Replicative form of M 13 clones was prepared by the rapid boiling procedure described 
by Maniatis et al. (37) for characterization of inserts. Single-stranded form of M 13 clones 
was prepared by a modification of the procedure of Schreier and Cortese (45) as described 
by New England Biolabs (sequencing kit 409;  Beverley, MA). Sequencing reactions uses 
E. coli DNA polymerase I, Klenow fragment, M 13 primer (pentadecamer) fragment, and 
mixtures of each of the four dideoxynucleotides with normal nucleotide precursors (New 
England  Biolabs),  as  well  as  a-[32P]dATP  (800  Ci/mmol;  New  England  Nuclear)  as  a 
source of label. Gel electrophoresis was on thin polyacrylamide gels, essentially as described 
by Sanger and Coulson (46). 
Results 
Production ofcDNA Clones.  Total poly(A)  + RNA was isolated from the C.C58 
M75 myeloma and subjected to formaldehyde gel electrophoresis. Hybridization 
with the 32p-labeled, nick-translated 3.1  kb C, probe (see Materials and Methods) 
demonstrated a  single hybridizing  1 kb species, approximately the size expected 
for a  kappa L  chain  mRNA.  Complementary DNA clones of the total poly(A)  + 
mRNA  were  made by the  method  of Okayama and  Berg (28).  Transformants 
were screened by colony hybridization with the 3.1-kb C, probe, and  11  strongly 
hybridizing colonies were identified,  all in the  RR1  strain.  Three of these were 
shown  by  restriction  enzyme  mapping  to  contain  inserts  of ~1,050  bp,  large 
enough to encode the entire M75  L  chain and 360 bp of flanking sequences. 
The  restriction  map  of  the  mouse  DNA  insert  in  plasmid  p9(35)  and  the 
strategy employed in determining its nucleotide sequence are illustrated  in Fig. 
1.  The presence of a  Bcl I  site was suspected from work of Max et al. (47), and 
to  use it  for cloning  into  M13mp6  and  M13mp9,  plasmid p9(35)  was  isolated 
after transformation  of E.  coli  K12  GM33  that  lacks the  dam  methylase system 
(30).  To analyze the sequence at the  3' end of the insert,  a  fragment of p9(35) 
was cleaved with Pvu II and treated with the enzyme Bal-31  for various periods, 
as described by Poncz et al. (48).  Samples at each time point were cleaved with 
Bcl I, and the fragments corresponding to the  3' end of the cDNA were cloned 
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FIGURE  1.  The strategy employed  in determining  the nucleotide  sequence of the cDNA 
insert of plasmid p9(35) is indicated by the arrows beneath the figure. Sequence from right to 
left (3' to 5' of the m RNA) was determined  from M 13mp8 clones, and from left to right (5' 
to 3' of the mRNA) was determined from M 13rap9 clones. Coding segments are indicated as 
follows: L, []; V, I-q;  j, I; C, FA. The 5' and 3' untranslated  regions appear as a solid line 
(  ), and  vector  is indicated  by a dashed  line (  ..... ).  The nucleotide  sequence of the  3' 
untranslated  region and poly(dAdT) segment from position 938  to approximately  position 
1,004 was not determined  (see text). GOLDRICK  El"  AL.  717 
into the Bcl |  and Hinc II sites of M 13mp8 for sequence analysis. The nucleotide 
sequence of 938 bp of the L chain cDNA insert of p9(35) is presented in Fig. 2. 
The sequence of ~66  bp at  the extreme  3'  end of the  3'  untranslated  region 
and the poly(dAdT) region, estimated at 50-60 bp, was not determined. 
Southern  Hybridization  of Genomic DNA  Fragments.  High  molecular  weight 
DNA from the C.C58  M75 myeloma and from livers of the C.C58, C58/J, and 
BALB/cAn strains of mice was digested with Bam HI, Hind III, or Eco RI and 
subjected to electrophoresis on 0.6% agarose gels. The DNA was transferred to 
nitrocellulose and hybridized to a ~2p-labeled probe consisting of a 200 bp Pst I- 
Kpn I fragment  that contained the 5'  untranslated  region (5'UT), leader,  first 
framework (Frl), and first complementarity determining  region (CDR 1) of the 
M75  ~ L  chain.  This  fragment  had  been cloned into the  plasmid  pUC18  (29) 
and radiolabeled as described in Materials and Methods. 
Comparison  of the  Bam  HI and  Hind  III  fragments  labeled in  C.C58  M75 
myeloma DNA with those in C.C58  liver DNA reveals in both digests a  unique 
hybridizing fragment in  the M75 DNA (Fig.  3a).  Further  studies not reported 
here  (M.  Goldrick,  P.  Ponath,  and  P.  Gottlieb,  unpublished  results)  indicated 
that  these  fragments  (7.4  and  4.0  kb  in  the  Bam  HI  and  Hind  III  digests, 
respectively) corresponded  to  the  rearranged  L  chain  gene  expressed  by this 
myeloma. The fragment shared by the M75 myeloma and C.C58 liver DNA (3.2 
and 2.8 kb in Bam HI and Hind III digests, respectively) is likely to correspond 
to an  unrearranged  germ  line gene homologous or identical  to that  expressed 
by the M75 myeloma. As expected, liver DNA from the C58/J strain, the source 
of the L chain genes of the C.C58 strain (22), contains similar common fragments. 
Of major interest is the finding that  the  Barn  HI and  Hind III digests of liver 
DNA  from  BALB/cAn,  the  strain  that  provided  the  genetic  background  of 
C.C58, and which does not express the genetic markers shown to be due to M75- 
like L chains (21, 22), contain strongly hybridizing fragments of 7.8 and 8.4 kb, 
respectively. V~Ser-related fragments of different size were also observed in Eco 
RI digests of C.C58 and BALB/c DNA (2.1 and 2.8 kb, respectively) (Fig. 3 b). 
Liver DNA from a  variety of inbred,  recombinant-inbred,  and  recombinant 
strains  was  then  digested  with  Bam  HI,  Hind  III,  or  Eco  RI,  and  tested  in 
Southern hybridizations with the VKSer-specific  probe. As summarized in Table 
I,  all  strains  that  express  the  IB-peptide  marker  and  the  Efl a polymorphism 
contain  strongly-hybridizing  fragments  of the  size  present  in  the  C.C58  and 
C58/J strains (Fig. 3, a and b). Strains that do not express these markers contain 
hybridizing  fragments  identical  in  size  to  those  of the  nonexpressing  strain, 
BALB/cAn. 
Discussion 
The nucleotide sequence of the 5'UT,  leader, and V segments of the C.C58 
M75 K chain cDNA clone p9(35) is aligned in  Fig.  2 with the sequences deter- 
mined for the BALB/c myeloma kappa chains MOPC21  (49) and MPC11  (50). 
These are two of the  BALB/c myeloma K chains  to which the  M75  L  chain  is 
most  homologous  (6).  To  maximize  homology,  the  36-bp  insertion  in  the  V 
segment of the MPC I I  sequence (50) has been omitted from the sequence (see 
Fig. 2 legend). The percentage differences observed when nucleotide sequences H75 
MOPC21 
MPCll 
M75 
HOPC21 
HPCll 
H75 
HOPC21 
HPCll 
H75 
MOPC21 
MPC11 
H75 
HOPC21 
HPC11 
H75 
MOPC21 
MPCll 
H75 
H75 
H75 
M75 
M75 
H75 
H75 
M75 
F 
5'UT  1o  5o 
(-29) 
gcgcgggg  ata  cat  cag  gca  ggc  aaa  ggc  arc  aag  atg  aag  tca  cag  acc  ca B  gtc  ttc  ata  ttt 
NNN  --g  ......  a-c  a--  -tg  ............  g-a  ........ t  -t ........... cc 
--g  .....  c  a-c  a--  -tg  ........ a  ---  g ......... tt  ........ t  g ....  c  FYoo 
-10  +10 
cta  ctg  ctc  tgt  gtg  tct  ggt  gct  cat  ggg  agt  att  gtg  atg  acc  cag  act  ccc  aaa  ttc  ctg 
a ..........  g  t-a  -a-  --a  ---  g ......  ac  .....  a  ........  a  t ......... c-  a-- 
g-g  t-t  .....  g  t .........  t-  g-c  --a  gac  ...............  t--  -a .......  a-- 
150 
+20  CDR1  +30 
cct  gta  tca  gca  gga  gac  agg  gtt  acc  atg  acc  tgc  aag  gcc  agt  cag  agt  gig  ggt  aat  aat 
t-c  a-g  ....  t  ......  g  .....  c  ---  t  .................  g--  -a  .....  t-  -c-  t-- 
t-c  ac  .....  t  ............  c  -g-  --c  ..................  ga  ....  a--  -c-  -c- 
200  250 
+40  +50  CDR2 
gta  gcc  tgg  tac  caa  cag  aag  cca  gga  ca B  tct  cct  aaa  ttg  ctg  ata  tac  tat  gca  tcc  aat 
--t  t-N  .....  t  ........  a  ....  ag  ............  c ....  c  .....  t  ggg  ........  c 
--g  ........  t  --g  .....  a  .....  g  --a  .........  c-a  .....  t  --ttc  .......  t-c 
300 
+60  +70 
cgc  tac  act  gga  gtc  cct  gat  cgc  ttc  act  ggc  agt  gga  tct  ggg  aca  gat  ttc  act  ttc  acc 
--g  ........  g  .....  N  ...........  a  .............  ca  ............  c-g  --- 
--g  ..............  c  ...........  N  ................. g  ............... 
350 
+80  +90  CDR3 
atc  agc  agt  gtg  cag  gtt  gaa  gac  ctg  gca  gtt  tat  ttc  tgt  cag  caa  cat  tat  ace  tot  cot 
................  c  .........  t  ....  a  ....  ca  ....  gga  --g  gg-  --c  -g-  -a-  --g 
................  c .........  a  ..........  a .................  gt  a ..... 
F'  ,oo  F  +100  +110 
eeg  acg  ttc  ggt  gga  ggc  acc  aag  ctg  gaa  atc  aat,  cgg  gct  gat  gct  gca  cca  act  gta  tcc 
t, K  & 
450  500 
+120  +130 
atc  ttc  cca  cca  tcc  agt  gag  cag  tta  aca  tct  gga  ggt  gcc  tca  gtc  gtg  tgc  ttc  ttg aac 
550 
+140  +150 
aac  ttc  tac  ccc  aaa  gac  arc  aat  gtc  aag  tgg aag  att  gat  ggc  agt  gaa  cga  caa  aat  ggc 
600 
+160  +170 
gtc  ctg  aac  agt  tgg  act  gat  cag  gac  agc  aaa  gac  agc  acc  tac  agc  atg  agc  age  acc  ctc 
650 
+180  +190  +200 
acg  ttg  acc  aag  gac  gag  tat  gaa  cga  cat  aac  agc  tat  acc  tgt  ga B  gcc  act  cac  aag  aca 
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of Fr  and  CDR  of the  M75,  MOPC21,  and  MPCll  L  chains  are  compared 
pairwise are  shown  in  Table  II. The  Frl,  Fr2,  CDR1,  CDR2,  and  leader plus 
5'UT  regions of M75  differ from the corresponding regions of MOPC21  and 
MPC1 1 by comparable amounts,  ranging from  16  to  28%.  In contrast,  Fr3  of 
M75  is more closely related,  differing at  13 and  5% of its nucleotides  from the 
corresponding region of MOPC21  and MPC1 1, respectively. Comparison of the 
MOPC21  and  MPC1 1  sequences  indicate  comparable differences  in  most seg- 
ments. 
The translated  amino acid sequence of the  C.C58  M7B  L  chain is compared 
in Fig. 4 with the amino acid sequences of BALB/c L chains, which appear to be 
most closely related to M75  ([3). It is immediately apparent that both  MOPC21 
and MPC11  contain leader sequences that are nine amino acids longer than that 
of the  M75  L  chain.  As summarized  in  Table  III, large  differences (39-40%) 
are observed between the leader and Fr I segments of the MTB L chain and those 
of MOPC21  and MPC11  at the positions over which  they can be compared.  In 
contrast,  the  Fr2  region  of MTB  is  nearly  identical  to  those  of MOPC21  and 
MPC11,  differing at only 7 and 0% of the amino acids, respectively. The amino 
acid  sequence  of Fr9  of M75  is  more  similar  to  the  corresponding  region  of 
MOPC21 and MPC11  than would be expected from differences at the nucleotide 
level (16% and  20%,  respectively). This is also evident when the Fr2 regions of 
MOPC21  and  MPC11  are compared.  One interpretation  of this finding is that 
selection at the protein level, perhaps for ability of the  L  chain to fold properly 
or  to  associate  with  H  chain,  may be acting  on  the  Fr2  region.  In  contrast  to 
Fr2, differences in amino acid sequence between M75 and the other proteins in 
Fr3 are what might be expected from their nucleotide sequences. 
The partial amino acid sequence most like that of M75 is that of the TEPC10 ] 7 
K chain (5,  52,  53) (Fig.  4).  Only five differences between  M7B  and TEPC1017 
are observed in  the  Frl  region;  three  fewer than  the  next most closely related 
protein.  Southern  hybridization  analysis  of  TEPC1017  myeloma  DNA  is  in 
progress to determine whether the expressed VK region has significant homology 
with the M75 V~ sequence. 
The J  segment  of the  C.C58  M75  K chain  is  nearly  identical  in  nucleotide 
sequence to that ofJ~l, the J  segment farthest upstream of the BALB/c CK gene 
(33, 54). The differences from BALB/c J~l at positions 381  and 382 (Fig. 2) may 
reflect junctional diversity introduced at position 96 of the L  chain by joining V 
FIGURE 2.  Tile sequence of nucleotides 1-938 of the cDNA insert of plasmid p9(35), which 
codes for the entire C.C58 M75 ~ chain, is shown. Arrows mark the beginning of the 5'UT, 
leader (L), V, J, c, and 3' untranslated  (3'UT) regions. CDR1, 2, and 3 are as designated 
according to Kabat et al. (6). Shown for comparison are the nucleotide sequences of the 5'UT, 
leader, and V segments of the BALB/c MOPC21 (49) and  MPC11 (50) myeloma K chains. 
The 36 bp insertion present  after nucleotide  114 in the MPC11 L chain sequence (50) has 
been omitted to allow comparison with the other L chains. Positions in MOPC21 and MPC 11 
that are identical to M75 are indicated by a dash (--). Positions where the sequence is not 
known are indicated by N. The ATG codon, which begins the L segment of M75, is numbered 
-20, and the last codon of the C region is numbered +214. The L segments of the MOPC21 
and MPC11 L chains are nine amino acids longer than that of M75, and begin at the codon 
numbered -29.  Shown in  boldface  type are the nucleotides  in  M75  that  differ from the 
germline sequences of BALB/c as determined by Max et al. (47, 54). The nucleotides present 
at the corresponding  positions in BALB/c are shown beneath the M75 sequence. 720  MOLECULAR GENETICS OF  MOUSE V~  POLYMORPHISM 
FIGURE 3.  Southern hybridization analysis of genomic DNA from the C.C58 M75 myelorna 
and from liver of the C.C58, C58/J, and BALB/cAn strains was performed as described in 
Materials and Methods. (a) Digestion was performed with Barn HI (1-4) and Hind Ill (5-8) 
on the following DNA samples: C58/J liver DNA (1 and 5); C.C58 liver DNA (2 and 6); 
C.C58 M75 myeloma DNA (3 and 7); and BALB/cAn liver DNA (4 and 8).  The sizes of 
molecular weight standards are given in  kb; (b) Digestion was performed  with Eco RI on 
BALB/cAn, C.C58, and C58/J liver DNA (1, 2, and 3, respectively). 
andJ gene segments.  The difference at nucleotide 416,  which results in substi- 
tution  of an  asparagine  at  position  107  in  M75  for a  lysine  in  BALB/c could 
reflect a  difference in  the germ line J  sequences of BALB/c and C.C58 strains, 
or  somatic  variation  in  the  expressed  M75  L  chain  gene.  The  basis  of these 
differences  will  become clear  from  nucleotide sequence  analysis  of the  C.C58 
germ line JK genes. 
Comparison of the nucleotide sequence of the CK region of the C.C58 M75  L 
chain with that of the unrearranged BALB/c C, gene (47) revealed a single silent 
substitution in the codon for isoleucine 205 of the M75 L chain (Fig. 2). The 3' 
untranslated  region  of the  M75  L  chain  cDNA differs  in  sequence  from  the GOLDRICK  ET  AL.  721 
TABLE  I 
Correlation of Expression of IB-peptide and EF  I" Phenotypes with Size of Restriction Fragments 
Containing V.Ser-related Genes 
Strain  IB  EfP 
Barn  HI  Hind  Ill  Eco  RI 
3.2*  7.8  2.8  8.4  2.1  2.8 
C.C58  +  +  +  -  +  -  +  - 
c58/j  +  +  +  -  +  -  +  - 
PL/J  +  +  +  -  +  -  +  - 
RF/J  +  +  +  -  +  -  +  - 
B6/Lyt-2  a,  Lyt-3 a  +  +  +  -  +  -  +  - 
AKR/J  +  +  +  -  +  -  +  - 
C.AKR  +  +  +  -  +  -  +  - 
NAK  NT*  +  +  -  +  -  NT  NT 
AKXL  13  NT  +  +  -  NT  NT  +  - 
AKXL  24  NT  +  +  -  NT  NT  +  - 
AKXL  25  NT  +  +  -  NT  NT  +  - 
AKXL  28  NT  +  +  -  NT  NT  +  - 
BALB/cAn  -  NT  -  +  -  +  -  + 
BALB/cJ  -  -  -  +  -  +  -  + 
C57BI/6J  -  -  -  +  -  +  -  + 
SjL/j  -  -  -  +  -  +  -  + 
CBA/J  -  -  -  +  -  +  -  + 
SWR/J  -  -  -  +  -  +  -  + 
C3H/HeJ  -  NT  -  +  -  +  -  + 
A/J  -  -  -  +  -  +  -  + 
B6.PL(85NS)  NT  -  -  +  NT  NT  -  + 
AKXL  5  NT  -  -  +  NT  NT  -  + 
AKXL  6  NT  -  -  +  NT  NT  -  + 
AKXL  7  NT  -  -  +  NT  NT  -  + 
AKXL  8  NT  -  -  +  NT  NT  -  + 
AKXL  9  NT  -  -  +  NT  NT  -  + 
AKXL  12  NT  -  -  +  NT  NT  -  + 
AKXL  14  NT  -  -  +  NT  NT  -  + 
AKXL  16  NT  -  -  +  NT  NT  -  + 
AKXL  17  NT  -  -  +  NT  NT  -  + 
AKXL  19  NT  -  -  +  NT  NT  -  + 
AKXL  21  NT  -  -  +  NT  NT  -  + 
AKXL  29  NT  -  -  +  NT  NT  -  + 
AKXL  37  NT  -  -  +  NT  NT  -  + 
AKXL  38  NT  -  -  +  NT  NT  -  + 
Most  of  the  lrpeptide  and  Efl a  phenotypes  have  been  reported  previously  (10,  18).  The  Efl 
phenotypes  of B6.PL(85NS)  and  NAK  mice  were  determined  by Gibson  et al.  (24,  25). 
*  Restriction  fragment  lengths  in  kb. 
*  NT,  not  tested. 
§ The  AKXL  29  strain  was  originally  typed  as  Efla-positive  (18).  The  strain  then  underwent  a 
breeding  crisis, and  was outcrossed  to  the  C57L/J  strain.  Progeny  were  backcrossed  four  times  to 
AKXL  29,  and  inbreeding  of the  resulting  mice  resulted  in  fixation  of the  AKXL  29  strain  for  the 
Efl b  allele  (B.  A. Taylor,  The  Jackson  Laboratory,  personal  communication). 
region  3'  to  the  embryonic  BALB/c  C,  gene  only  at  nucleotide  758  (Fig.  2).  If 
the  C.C58  C,  gene  is  derived  from  the  C58/J  strain,  then  the  nearly  complete 
conservation  of  this  region  suggests  that  it  may  determine  some  important 
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TABLE  II 
Comparison of Nucleotide Sequences of 5' Untranslated Region and 
Leader, Framework, and Complementarity-determining Regions of 
M75, MOPC21, and MPC11 L Chains 
Nucleotide differences between:* 
M75 and  M75 and  MOPC21 and 
MOPC21  MPC11  MPCI 1 
% 
5'UT +Ieader  22  28  22 
Frl  22  21'  15' 
CDR1  21  20  25 
Fr2  16  20  14 
CDR2  25  25  20 
Fr3  13  5  12 
CDR3  50  15  55 
Segments compared are as defined by Kabat et al. (6): 5'UT and leader, 
9-95; Frl, 96-164;  CDR1,  165-197;  Fr2,  198-242;  CDR2, 243-263; 
Fr3,264-359;  CDR3, 360-380. 
* Wherever  N  appears  in  the  nucleotide  sequences  of  MOPC21  and 
MPC11  in Fig. 2, these comparisons assume that the nucleotide at that 
position is same as in M75. 
* The 36-bp insertion that follows nucleotide 113 in the Frl region of the 
MPCI 1 L chain mRNA sequence (50)  has been omitted in these com- 
parisons. 
POSITION 
M75 
MOPC21 
MPC11 
J604 
TEPC1017 
HPC35 
T15CR 
-2o  -lo  1  to  2o  30  ,o 
I  -  Le"der  -  I  Frl  I  CDR'  I 
MKSOTOVFIFLLLCVSGAHGSIV"IOIPKFLPVSAGDRVTMTCKASQSVGNNVAWYQQKP 
NHQTSMGIK-E---L---SI'-WLY--D-N  .....  S--SMSM-V-E---L  .....  EN-VTY-S ...... 
MHHTSMGIK-E--I---V-VF-WL--VD-D  .....  SH--MST-V ....  St ......  D-STT ........ 
D  .....  SQ--MST-V ....  SV  ......  N--T .... 
N  ..........  LM-S .....  I ....  A-A-S-D-- 
D  .....  S--SMS--V-E---L  .....  EN-VIY-  " 
POS I T l ON  50  60  70  80  90  100  110 
--Fr2~-CDR2Jr  -~  Fr3  t  CDR3~--~Fr4~ 
M75  GQSPKLL  I YYAS NRYTGVPDRFTGSGS 6TI)FTFT 1  SSVQVEDLAVYFCQQHYTSPPIFGGGTKLE l NRAD 
MOPC21  E ........  G  .................  A ....  L ......  A ....  D-H-G-G-SY-Y ..........  K 
MPC11  .........  S--Y ..........................  A ......  Y .....  ST ............  K 
FIGURE 4.  Comparison of the translated amino acid sequences of the leader and  V regions 
of the C.C58 M75 L chain, and the most closely related known BALB/c ~ L chains, as obtained 
from  Kabat  et al.  (6).  Amino acid  residues are represented  by a  one-letter code  (51).  12 
additional amino acid residues, which precede position  1 of the MPC11  L chain, the result of 
a  36-bp  insertion  (50),  have  been  omitted  to allow comparison  with  the  other  sequences. 
Positions of the leader, FR, and CDR are as defined by Kabat et al. (6). The beginning of the 
J  segment is indicated by an arrow (~). Positions at which the sequence is identical to M75 are 
indicated by a dash (--). 
Finally, Southern  hybridization  experiments  have demonstrated  that  a  V,Ser- 
specific probe  corresponding  to the 5'UT  region,  leader,  Frl,  and  CDR1  of the 
M75  g  chain  hybridizes  strongly  to  restriction  fragments  of liver DNA  from  all 
inbred,  recombinant,  and  recombinant  inbred  strains  tested.  Under  stringent 
hybridization  conditions,  one strongly  hybridizing  DNA  fragment  is observed  in 
Barn  HI,  Hind  lII, and  Eco RI digests (Fig.  3, a  and  b),  and  based  on  the size of 
the fragments,  strains could be divided into two groups.  The  presence  of strongly GOLDRICK  ET  AL.  723 
TABLE III 
Comparison of Amino Acid Sequences of Leader, Fr, and CDR of 
M75, MOPC21, and MPCI I L Chains 
Amino acid differences between: 
M75 and  M75 and  MOPC21 and 
MOPC21  MPC11  MPC11 
Leader  40  45  31 
Frl  39  39*  30* 
CDR1  55  36  46 
Fr2  7  0  7 
CDR2  14  29  29 
Fr3  16  6  13 
CDR3  56  22  44 
Segments compared are defined with respect to Fig. 4 as follows: leader, 
-20-  -1;  Frl,  1-23; CDR1, 24-34; Fr2, 35-49;  CDR2,  50-56;  Fr3, 
57-88; CDR3, 89-97. 
* The  12-amino acid segment that precedes residue 1 of the MPC11  L 
chain and results from a 36-bp insertion (50)  has been omitted in these 
comparisons. 
hybridizing Bam HI, Hind III, and Eco RI fragments of 3.2,  2.8, and 2.1  kb, 
respectively, was found to correlate completely with expression by the strain of 
the IR-peptide and Efl a markers (Table I). All nonexpressor strains had strongly 
hybridizing Barn HI, Hind III, and Eco RI fragments of 7.8,  8.4, and 2.8  kb, 
respectively. In addition, in some Southern hybridizations (e.g.  Fig.  3b)  more 
weakly hybridizing bands are observed with DNA from strains of both groups, 
and preliminary results suggest that the size distribution of these bands may also 
be  characteristic  of each  group.  Whether  or  not  these  bands  contain  genes 
belonging to the same V~ gene family as the strongly-hybridizing fragment is not 
yet known. Finally, it is not known whether differences in flanking regions that 
give rise to the restriction polymorphisms observed also determine expression of 
VKSer L  chains by one group of strains and not by the other. Analysis of the 
DNA surrounding the V~Ser-like  genes in strains of both groups should shed 
light on this question, and may provide clues to the genetic events that resulted 
in divergence of the two classes of strains in this chromosomal region. 
Until this study, one possible explanation for expression of L chain phenotypic 
markers associated with the V~Ser  group was that strains that do not express 
these markers lack V~Ser-like  genes altogether. Siekevitz et al. (55)  have shown 
that strains that do not express the major crossreactive idiotype of antiarsonate 
antibodies of A/J mice lack the single strongly hybridizing VH gene present in 
idiotype-positive strains. This is not the case for strains that do not express V~Ser- 
associated markers, as shown by our Southern hybridization experiments, which 
show  strongly  hybridizing sequences  in  all  strains  tested.  A  second  possible 
explanation is that the V~Ser-like genes present in strains that do not express the 
IB-peptide  and Efl" markers contain differences in the coding regions that alter 
the structure of the products so that they are undetectable in the assays for the 
pbenotypic markers.  If this were so,  their products might nevertheless be  ex- 
pected  to  occur  at  random  in  the  large  BALB/c myeloma collection (6).  As 724  MOLECULAR  GENETICS  OF  MOUSE  VK  POLYMORPHISM 
shown  here,  even  the  most closely related  BALB/c myeloma or  hybridoma  K 
chains  observed differ  markedly  from  the  M75  L  chain  (Figs.  2  and  4).  The 
frequency of expression of the BALB/cAn V.Ser-like L chain genes would appear 
to be very low. In contrast,  V.Ser-like L chains were observed with an incidence 
of at least 7 out of a  total of ~200 C.C58 and C.AKR myelomas induced (21). 
Results of studies in progress (J. Bednarczyk and P. Gottlieb, unpublished results) 
using  the  V.Ser-specific  probe  to  analyze  BALB/c  hybridomas  by  the  ]ysate 
hybridization method of Manser and Gefter (56) should provide information on 
the expression of V.Ser-like genes in this strain. 
It is possible that V.Ser-like genes of strains that do not express V~Ser-associated 
markers contain  in-frame termination  codons in coding regions or mutations in 
promoter, splicing, recombination, or other signals required for their expression. 
Nucleotide sequence analysis of cloned unrearranged  V,Ser-like genes from liver 
DNA of both BALB/cAn and C.C58 strains should show whether or not V.Ser- 
like  genes  of BALB/cAn  are  defective in  coding  or  regulatory  sequences,  or 
conversely, whether C.C58 V.Ser-like genes contain unusual flanking sequences 
that may affect their expression. These studies are in progress. Only one strongly 
hybridizing fi-agment and one V~Ser-like gene has been identified to date in each 
strain  (M.  Goldrick, T.  Boyd, P.  Ponath,  and  P.  Gottlieb,  unpublished results). 
However, multiple clones must be analyzed, as shown by results of Siekevitz et 
al.  (57),  who  isolated  three  different  V~  genes  related  to  the  V.  gene  that 
determines the major crossreacting anti-Ars idiotype of A/J mice from a single 
hybridizing 6.4 kb band of genomic DNA. 
Our  studies  on  the  strain-specific  nature  of V~Ser  gene  expression  may  be 
compared with studies by Bothwell et al.  (58) and  Loh et al.  (59) on the strain- 
specific expression of certain V, regions in the response of C57BL/6 mice to the 
(4-hydroxyl-3-nitrophenyl)acetyl (NP) hapten. Whereas only one strongly hybrid- 
izing V,Ser-related  fragment  is detected in  DNA of strains  that  do and do not 
express  the  l~-peptide  and  Efl ~ markers,  those  workers  detected  multiple  in- 
tensely-hybridizing  fragments  in  strains  that  do  and  do  not  express  the  NP  b 
idiotype.  Loh and coworkers showed that  in  C57BL/6 mice, only one of these 
V. genes was used in the response to NP, and that none of the related genes in 
BALB/c were used, three being pseudogenes, and two containing  CDR differ- 
ences that make them unlikely to be useful for anti-NP antibodies. BALB/c mice 
use different  V.  genes  to produce anti-NP  antibodies  (59).  Since  the antigen- 
binding specificity of C.C58 antibodies containing V.Ser L chains is not known, 
we are unable to use immunization  to help determine whether failure to express 
VKSer-associated phenotypic  markers  reflects  use  by nonexpressor  strains  of a 
different K chain  group.  However, studies of germline  V.Ser-like genes should 
reveal whether it is at least possible for phenotypically-negative strains to express 
the I.-peptide and Efl ~ markers. 
Summary 
Previous studies (21) have shown that two mouse K light (L) chain variable (V) 
region polymorphisms,  the IB-peptide and  Ell ~ markers,  reflect expression of a 
characteristic group of V~ regions, called V.Ser, by some inbred strains and not 
others.  Expression  of V.Ser  is  controlled  by a  locus  on  chromosome  6,  the GOLDRICK  ET  AL.  725 
chromosome that contains the ~ locus. To further characterize this V, group and 
begin to analyze the basis for its strain-specific expression, full-length comple- 
mentary DNA (cDNA) copies were produced of L chain mRNA from the M75 
myeloma that had been induced in the C.C58 strain of mice, and which produces 
a V~Ser L chain. The C.C58 strain is congenic with BALB/cAn, differing in the 
region of chromosome 6 that controls expression of the V, polymorphisms and 
the Lyt-2 and Lyt-3 T  cell alloantigens. The complete nucleotide sequence of 
this cloned cDNA was determined and compared with the nucleotide sequences 
the most closely related BALB/c myeloma L  chains known. Results indicated 
significant differences throughout the variable region, but particularly toward 
the 5' portion of the sequence. A probe corresponding to 200 bp of the 5' end 
of the cloned VKSer cDNA was used in Southern hybridizations of restriction 
digests of liver DNA from a number of inbred, recombinant, and recombinant 
inbred strains. Under stringent hybridization conditions, one strongly-hybridiz- 
ing fragment was observed in Barn HI, Hind III, and Eco RI digests, and based 
on the size of the fragments, strains could be organized into two groups. The 
presence of strongly hybridizing Barn HI,  Hind III, and Eco RI fragments of 
3.2,  2.8,  and  2.1  kb,  respectively,  was  found  to  correlate  completely  with 
expression by the strain of the Is-peptide and Efl  a markers. All nonexpressor 
strains  yielded  hybridizing  fragments  of  7.8,  8.4,  and  2.8  kb,  respectively. 
Possible explanations for  strain-specific expression  of V~Ser-associated pheno- 
typic markers are discussed. 
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